1. Home
  2. SNY vs MELI Comparison

SNY vs MELI Comparison

Compare SNY & MELI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNY
  • MELI
  • Stock Information
  • Founded
  • SNY 1994
  • MELI 1999
  • Country
  • SNY France
  • MELI Uruguay
  • Employees
  • SNY N/A
  • MELI N/A
  • Industry
  • SNY Biotechnology: Pharmaceutical Preparations
  • MELI Catalog/Specialty Distribution
  • Sector
  • SNY Health Care
  • MELI Consumer Discretionary
  • Exchange
  • SNY Nasdaq
  • MELI Nasdaq
  • Market Cap
  • SNY 123.6B
  • MELI 107.9B
  • IPO Year
  • SNY N/A
  • MELI 2007
  • Fundamental
  • Price
  • SNY $52.13
  • MELI $2,410.00
  • Analyst Decision
  • SNY Buy
  • MELI Strong Buy
  • Analyst Count
  • SNY 2
  • MELI 14
  • Target Price
  • SNY $62.50
  • MELI $2,519.29
  • AVG Volume (30 Days)
  • SNY 3.1M
  • MELI 397.9K
  • Earning Date
  • SNY 04-24-2025
  • MELI 05-07-2025
  • Dividend Yield
  • SNY 3.09%
  • MELI N/A
  • EPS Growth
  • SNY 39.56
  • MELI 82.42
  • EPS
  • SNY 5.45
  • MELI 40.65
  • Revenue
  • SNY $48,817,552,946.00
  • MELI $22,379,000,000.00
  • Revenue This Year
  • SNY $5.35
  • MELI $27.06
  • Revenue Next Year
  • SNY $6.69
  • MELI $23.40
  • P/E Ratio
  • SNY $9.56
  • MELI $59.28
  • Revenue Growth
  • SNY N/A
  • MELI 43.27
  • 52 Week Low
  • SNY $45.80
  • MELI $1,550.00
  • 52 Week High
  • SNY $60.12
  • MELI $2,501.00
  • Technical
  • Relative Strength Index (RSI)
  • SNY 44.93
  • MELI 68.55
  • Support Level
  • SNY $51.67
  • MELI $2,206.88
  • Resistance Level
  • SNY $55.73
  • MELI $2,349.00
  • Average True Range (ATR)
  • SNY 0.90
  • MELI 73.17
  • MACD
  • SNY 0.10
  • MELI 14.67
  • Stochastic Oscillator
  • SNY 31.69
  • MELI 80.61

About SNY Sanofi ADS

Sanofi develops and markets drugs with a concentration in vaccines, immunology, oncology, cardiovascular disease, diabetes, and over-the-counter treatments. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing about 30% of total sales, but profits are shared with Regeneron. Just over 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.

About MELI MercadoLibre Inc.

MercadoLibre runs the largest e-commerce marketplace in Latin America, with more than 218 million active users and 1 million active sellers across 18 countries stitching into its commerce network or fintech solutions when last reported. The company operates a host of complementary businesses to its core online shop, with shipping solutions (Mercado Envios), a payment and financing operation (Mercado Pago and Mercado Credito), advertisements (Mercado Clics), classifieds, and a turnkey e-commerce solution (Mercado Shops) rounding out its arsenal. MercadoLibre generates revenue from final value fees, advertising royalties, payment processing, insertion fees, subscription fees, and interest income from consumer and small-business lending.

Share on Social Networks: